Excelsior Biopharma Inc. (TPEX:6496)

Excelsior Biopharma Revenue

Excelsior Biopharma had revenue of 232.49M TWD in the quarter ending June 30, 2026, with 15.10% growth. This brings the company's revenue in the last twelve months to 936.92M, up 7.59% year-over-year. In the year 2025, Excelsior Biopharma had annual revenue of 898.26M with 4.22% growth.

• Revenue (ttm): 936.92M
• Revenue Growth: +7.59%
• P/S Ratio: 1.23
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.15B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	898.26M	36.35M	4.22%
Dec 31, 2024	861.91M	90.35M	11.71%
Dec 31, 2023	771.56M	99.80M	14.86%
Dec 31, 2022	671.76M	-666.63M	-49.81%
Dec 31, 2021	1.34B	-105.27M	-7.29%

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 5, 2026

Data Sources Report a data error